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Background: Because survival after pancreaticoduodenectomy for cancer is limited, it is difficult to
assess longterm pancreaticojejunal anastomotic patency. However, in patients with benign disease,
pancreaticojejunal anastomotic stenosis may become problematic. What happens when pancreaticoje-
junal anastomosis revision is undertaken?
Methods: Patients undergoing pancreatic anastomotic revision after pancreatic head resection for
benign disease between 1997 and 2007 at the Medical University of South Carolina were identified. A
retrospective chart review and analysis were undertaken with the approval of the Institutional Review
Board for the Evaluation of Human Subjects. Longterm follow-up was obtained by patient survey at a
clinic visit or by telephone.
Results: During the study period, 237 patients underwent pancreatic head resection. Of these, 27
patients (17 women; median age 42 years) underwent revision of pancreaticojejunal anastomosis. Six
patients (22%) had a pancreatic leak or abscess at the time of the index pancreatic head resection. The
indication for revision of anastomosis was intractable pain. All patients underwent preoperative magnetic
resonance cholangiopancreatography (MRCP), which indicated anastomotic stricture in 18 patients
(63%). Nine other patients underwent exploration based on clinical suspicion caused by recurrent
pancreatitis and stenosis was confirmed at the time of surgery. Six patients (22%) had perioperative
complications after revision. The median length of stay was 12 days. There were no perioperative deaths;
however, late mortality occurred in four patients (15%). Six of 23 survivors (26%) at the time of follow-up
(median 56 months) reported longterm pain relief.
Conclusions: Stricture of the pancreaticojejunal anastomosis after pancreatic head resection presents
with recurrent pancreatitis and pancreatic pain. MRCP has good specificity in the diagnosis of anasto-
motic obstruction, but lacks sensitivity. Pancreaticojejunal revision is safe, but rarely effective, as a means
of pain relief in patients with the pain syndrome associated with chronic pancreatitis.
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Introduction
The Achilles heel of pancreatoduodenectomy is the pancreaticoje-
junal anastomosis. Early anastomotic failure is measured by the
development of postoperative pancreatic fistula and consequent
complications of abscess or haemorrhage. Late failure of the pan-
creaticojejunostomy is measured by the development of anasto-
motic stenosis and the complication of exocrine and endocrine
insufficiency.
Longterm outcomes formost gastrointestinal anastomoses have
been evaluated and defined. Gastrojejunostomy after Roux-en-Y
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gastric bypass for weight loss becomes stenotic in 4.9–6.0% of
cases and is almost always successfully managed with endoscopic
balloon dilation.1,2 Hepaticojejunostomy for reconstruction after
a common bile duct injury is complicated by anastomotic stenosis
in 9% of cases and is amenable to successful endoscopic or radio-
graphic dilation in 69% of these.3 The low rectal anastomosis
develops a symptomatic stricture in 0–6.6% of cases and is
managed endoscopically in the majority of these.4 By contrast,
longterm outcomes and management strategies for pancreaticoje-
junostomy after pancreatic head resection have not been well
examined. One of the issues involved in assessing the scope of the
problem and the incidence of pancreaticojejunal anastomotic
stricture formation is that most pancreatic head resections are
performed for malignant disease with poor survival and thus few
patients are available for longterm follow-up. Longterm pancre-
aticojejunal anastomotic durability has not been well examined;
similarly the management of pancreaticojejunal anastomotic
stenosis has not been assessed.
Therefore, we performed a retrospective review and analysis
of patients who underwent pancreatic head resection for benign
disorders of the pancreas with subsequent operative revision for
pancreaticojejunal stenosis in order to evaluate patient outcomes
after the surgical management of anastomotic failure.
Materials and methods
All patients undergoing pancreatic head resection for benign
disease in the Section of Gastrointestinal Surgery at the Medical
University of South Carolina Digestive Diseases Center between
1997 and 2007 were identified from an institutional database.
Those patients who underwent a second, revisional pancreatic
procedure during the time period were selected. A retrospective
chart review and analysis from the inpatient and outpatient
electronic medical record systems were undertaken. Patient data,
including demographics, presenting diagnosis, perioperative
course and details of outpatient follow-up, were noted.
Longterm follow-up was obtained by patient survey at a patient
clinic visit or by telephone assessment. A good longterm clinical
outcome was determined by the patient’s report of improvement
or resolution of pancreatic pain as a result of the revisional pan-
creatic operation. A poor outcome was defined by a patient’s
report of pain as unchanged or worsened after surgery. This study
was approved by the Institutional Review Board for the Evaluation
of Human Subjects.
Results
During the study time period, 237 patients (123 women; median
age 45 years, range 15–74 years) underwent pancreatic head resec-
tion for benign disease in the Section of Gastrointestinal Surgery,
Medical University of South Carolina. Of these, 161 procedures
were performed for chronic pancreatitis (68%). Other diagnoses
included intraductal papillarymucinous neoplasm (IPMN), cystic
neoplasm and autoimmune pancreatitis. Of the 237 patients, 27
(11.3%;17women;median age 42 years, range 15–72 years;median
body mass index 25 kg/m2, range 17–51 kg/m2) underwent subse-
quent revision of pancreaticojejunal anastomosis.
In 24 patients the indication for the index pancreatic head
resection was intractable pain secondary to chronic pancreatitis
(89% vs. 68% in the overall group; P < 0.04) (Table 1). The aeti-
ology of chronic pancreatitis was sphincter of Oddi dysfunction
(12 patients, 50%), pancreas divisum (five patients, 21%), ethanol
(three patients, 13%) and idiopathic (four patients, 17%). Two
patients underwent pancreatic head resection for IPMN and one
for autoimmune pancreatitis (Table 2). Twenty-two patients
underwent pancreaticoduodenectomy and five underwent duode-
nal preserving pancreatic head resection (Beger procedure).5
All underwent pancreaticojejunal anastomosis with a duct-to-
mucosa technique, using interrupted absorbable monofilament
sutures. Three involved a second outer layer of interrupted silk
sutures including the pancreatic capsule and small bowel sero-
muscular layer. In 24 patients a 5F paediatric feeding tube was
inserted as a temporary anastomotic stent. Four patients (14.8%)
had a pancreatic leak and two (7.4%) had a perianastomotic
abscess in the postoperative period after this index operation.
The 27 patients identified in this series presented at a median
of 12 months (range 2–99 months) after pancreatic head resection
with abdominal pain and pancreatitis. All underwent magnetic
resonance cholangiopancreatography (MRCP), which indicated
anastomotic stricture in 18 patients (67%). Pancreaticojejunos-
tomy stricture was evidenced by narrowing at the anastomosis
accompanied by upstream dilation (Fig. 1). In four patients, the
Table 1 Data for subjects undergoing pancreatic head resection
during 1997–2007
Overall Pancreaticojejunal
stenosis
P-value
Patients, n 237 27
Median age, years 45 42 NS
Women, n (%) 123 (51.9%) 17 (63%) NS
Chronic pancreatitis,
n (%)
161 (67.9%) 24 (88.9%) 0.04
NS, not significant
Table 2 Indications for index pancreatic head resection
Diagnosis Patients, n (%)
Chronic pancreatitis 24 (89%)
Sphincter of Oddi
dysfunction
12
Pancreas divisum 5
Ethanol 3
Idiopathic 4
Intrapapillary mucinous
neoplasm
2 (7%)
Autoimmune pancreatitis 1 (4%)
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pancreatic duct was only mildly prominent (2.5 mm), but showed
persistent dilation >1 mm from baseline at 15 min after secretin
administration. The median main pancreatic duct diameter was
3.5 mm (range 2.5–7.0 mm) overall and 4.0 mm (range 2.5–
7.0 mm) in the abnormal studies; four patients had pseudocysts.
Nine other patients were identified based on strong clinical sus-
picion of anastomotic stricture arising from episodes of recurrent
pancreatitis (Table 3).
Three patients underwent endoscopic management of the anas-
tomotic stenosis attempted prior to operative revision. In one, the
pancreaticojejunal orifice was unable to be located. In another, the
anastomosis was located but therapeutic intervention was unsuc-
cessful as a result of positioning. The third patient suffered endo-
scopic perforation during attempted navigation of the afferent
gastrojejunal loop.
The technique of anastomotic revision varied depending on the
underlying disorder, the size of the pancreatic duct and the degree
of pancreatic fibrosis. The pancreaticojejunostomy was taken
down and examined. In most cases it was obliterated and not
patent. Anastomotic stenosis was confirmed in all patients at the
time of surgery. The pancreas was then opened along the pancre-
atic duct for a variable distance. A pancreaticojejunostomy with
interrupted permanent suturing was performed using the same
limb of small bowel in 24 cases and a separate Roux-en-Y limb in
three. Most patients had a duct-to-mucosa anastomosis. In one
patient, a dunking technique was employed. In two patients the
anastomosis included an existing pseudocyst.
Six patients (22%) had a complication after the reoperative
procedure. Two patients suffered a pancreatic anastomotic leak; in
one patient this required percutaneous transhepatic cholangio-
Figure 1 Secretin stimulated magnetic resonance cholangiopancreatogram image demonstrating pancreaticojejunal anastomotic stenosis,
evidenced by signal void at the obliterated anastomosis (A), accompanied by upstream main pancreatic duct dilation (B). Also visualized are
the jejunal limb (C) and the choledochojejunostomy (D).
Table 3 Magnetic resonance cholangiopancreatography findings
in the 27 patients who presented at a median of 12 months after
pancreatic head resection with abdominal pain and pancreatitis
Result Finding Patients, n Total
Abnormal 18
Stenosis with dilated upstream
pancreatic duct
14
Persistent pancreatic duct dilation
after secretin stimulation
4
Normal 9
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gram catheter placement to divert bile and in the other the leak
resolved without intervention. One patient had a perianastomotic
abscess requiring image-guided percutaneous drainage. Two
patients suffered catheter-related sepsis. One patient required
re-intubation with a 2-day ventilatory course secondary to respi-
ratory insufficiency. The median length of stay was 12 days (range
4–24 days).
There was no perioperative mortality. However, four patients
(15%) died during the follow-up period. All four patients had a
diagnosis of chronic pancreatitis. Two patients died 5.5 years and
2.3 years post-revisional surgery of malnutrition. Both had under-
gone subsequent completion pancreatectomy with islet auto-
transplantation (TP/IAT). Another patient committed suicide 11
months post-surgery and one died at home of unknown causes
5 years after surgery.
Longterm follow-up was obtained from the 23 survivors at a
median of 56 months post-procedure (range 23–126 months). Six
of these 23 patients (26%) reported a good outcome in terms of
pain relief after the revisional operation. Five of the six patients
with a good outcome had an initial diagnosis of chronic pancre-
atitis and the sixth had autoimmune pancreatitis. Two of the six
patients continue to take narcotic analgesic medication daily or
several times a week despite reporting a good outcome.
Discussion
Pancreatic head resection is performed increasingly for benign
disease. Hence, longterm outcomes, particularly of the pancreati-
cojejunal anastomosis, have become notable.
Recently, Reid-Lombardo and colleagues at the Mayo Clinic
reviewed their experience with pancreaticoduodenectomy for
benign disease (122 patients, 40% chronic pancreatitis) and found
four (3.3%) with pancreaticojejunal stenosis. Patients presented
with abdominal pain, diarrhoea and recurrent pancreatitis evi-
denced by pseudocyst on imaging. Management included an
endoscopic approach in two and surgical revision in two cases.
The authors reported a good outcome in all four patients.6
The current series has a higher incidence of symptomatic
anastomotic stenosis (11.3% vs. 3.3%) than the Mayo series. This
discrepancymay reflect the larger proportion of patients overall in
this series with chronic pancreatitis (68% vs. 40%). Chronic pan-
creatitis was found to be a risk factor for pancreaticojejunostomy
stenosis in this series (68% overall vs. 89% in the stenotic group;
P < 0.04). Thus, one might speculate that the inflammatory and
fibrosing process inherent in pancreatitis might lend itself to pan-
creaticojejunostomy anastomotic stricture. In addition, this series
had a worse outcome in terms of pain relief than the Mayo series
(26% vs. 100% of patients indicated a good outcome). This dif-
ference, too, may be ascribed to a higher incidence of chronic
pancreatitis because 24 of the 27 patients with anastomotic steno-
sis in this series suffered from chronic pancreatitis, whereas only
one of the four patients in the Mayo series did.6 Clearly, the pain
syndrome associated with chronic pancreatitis is complex and
often multifactorial.
In most gastrointestinal anastomoses, ischaemia has been
implicated in anastomotic failure; the pancreaticojejunostomy
is no exception. Strasberg and colleagues found in a pros-
pective evaluation that 38% of patients undergoing pancreati-
coduodenectomy had evidence of inadequate pancreatic blood
supply to the cut edge of the pancreas at the time of anastomosis.
They recommended cutting back the pancreas to the healthy
bleeding gland prior to proceeding with pancreaticojejunostomy
to prevent early anastomotic failure (pancreatic fistula).7 Cer-
tainly, ischaemia may also play a role in longterm pancreatic anas-
tomotic failure. As the current series is a retrospective study,
the occurrence of pancreatic neck ischaemia and its relationship
to pancreaticojejunostomy stenosis is not easily assessed.
Demographically, the patients in this series who underwent
revision of pancreaticojejunostomy stricture were similar to those
who underwent pancreatic head resection for benign disease and
did not undergo stricture revision. A total of 63% were women,
compared with 56% of the entire group (P = not significant [NS]).
The median age of the patients was 42 years, compared with 45
years in the entire group (P = NS). There were insufficient data to
compare the body mass index between groups.
The patients with pancreaticojejunostomy stricture identified
in this series presented with abdominal pain. Steatorrhoea was not
a significant clinical feature. Most patients, however, were already
taking pancreatic enzyme supplementation and faecal fat studies
were not performed in any patient.
Magnetic resonance cholangiopancreatography was the
primary mode of evaluation for the patient presenting with
abdominal pain post-pancreatic head resection with suspected
pancreaticojejunostomy stenosis. Two-thirds of patients had an
abnormal study suggestive of stenosis. Therefore, a positive test
was useful. The use of secretin-stimulated MRCP to assess for
pancreatic anastomotic stenosis8,9 or papillary stenosis in the
patient with native anatomy10–12 has been described, although only
in small series, with conflicting reported accuracy. Interestingly,
Nordback and colleagues evaluated 26 consecutive asymptomatic
patients after pancreatic head resection with functional MRCP
and found that 48% had at least partial pancreaticojejunostomy
anastomotic obstruction.9
As a confounding factor, however, the consistent use of secretin
stimulation in magnetic resonance evaluation of the pancreas
in our institution was employed only during the latter portion of
the time period referred to in this series. In addition, two of the
studies were performed at outside centres. Therefore, as a result of
the variability of study protocol and quality, we cannot draw
definitive conclusions about the significance of a negative test
from this experience.
The third of patients without MRCP evidence of pancreaticoje-
junostomy stricture were subjected to exploration based on clini-
cal, laboratory or radiographic evidence of recurrent pancreatitis,
considered an indirect indicator of pancreaticojejunostomy steno-
sis. Anastomotic narrowing or obliteration was confirmed in
all patients by the surgeon at surgery. It is important to note,
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however, that this finding was a subjective evaluation made by the
surgeon and no objective measurements were taken. The MRCP
result was not predictive of outcome.
Several authors have reported on adjunctive techniques for
the successful endoscopic navigation of surgically altered foregut
anatomy.13 Endoscopic management was attempted in only three
cases in this series, all of which failed. The challenges to endo-
scopic intervention are illustrated by these three failures: difficult
navigation of altered anatomy with risk of perforation; loss of
landmarks to allow identification of the pancreaticojejunostomy
anastomosis, particularly when stenotic, and awkward positioning
once the anastomosis is identified, potentially precluding thera-
peutic intervention.
The anastomotic revision in all cases entailed opening the pan-
creatic duct along the pancreas anteriorly for as long as it could be
followed, and then performing a lateral pancreaticojejunostomy
either to the same limb of jejunum or to a new Roux-en-Y limb, as
length would allow. This technique was used to allow the greatest
chance of ductal and parenchymal decompression and to mini-
mize the chance of recurrence of stenosis. Interestingly, the
median pancreatic duct diameter was 3.5 mm in all patients in the
series. The pancreatic duct was >5 mm in diameter in only seven
patients and >7 mm in only two. It has previously been shown
that pancreatic duct and parenchymal drainage with lateral pan-
creaticojejunostomy is unsuccessful for pain relief in patients with
small duct chronic pancreatitis (pancreatic duct diameter <7 mm
in diameter).14 Therefore, the poor outcomes for pain relief in this
study may not have been entirely unexpected.
The high late mortality (15%) observed in this series reflects
the difficulties facing this challenging patient population, in which
surgical management of chronic pancreatitis fails. Although
ethanol abuse has been identified as a risk factor for increased
mortality associated with chronic pancreatitis,15 none of the
patients in the study who died had alcohol-related pancreatitis.
The pain relief outcomes noted in this series are disappointing,
with only six patients (26%) reporting improvement in their pain
after anastomotic revision. In addition, of these six patients, two
still require chronic narcotic analgesia medication. One might
debate the underlying problems presented by psychosocial patient
disorders, methods of diagnosis, operative technical consider-
ations and perioperative indicators predisposing to pancreaticoje-
junostomy stenosis.What is not debatable is that in this cohort of
patients operative intervention with pancreaticojejunostomy revi-
sion was of little value. Given the heterogenous and multifactorial
nature of the neuropathic pain syndromes associated with chronic
pancreatitis, this is not surprising. Relief of anastomotic obstruc-
tion does not address the central and splanchnic neural contribu-
tors to pancreatic pain and nor does it ameliorate the underlying
disorder of exaggerated pancreatic fibrosis. The relief of pain
associated with chronic pancreatitis is without doubt more com-
plicated than the correction of pancreatic duct obstruction.
Thoracic splanchniciectomy and coeliac neurolysis have been
advocated by some authors as alternative strategies for refractory
pain after pancreatic surgery for chronic pancreatitis. Although
they are effective, both techniques have unfortunately shown
limited durability.16,17
An alternative measure in patients with continued pain after
previous pancreas surgery is total (completion) pancreatectomy.
This reoperative approach has been shown to be effective in reliev-
ing pain in carefully selected patients.18 In the past, total pancre-
atectomy was avoided because of resultant severe diabetes marked
by potentially life-threatening hypoglycaemic episodes. With the
advent of islet autotransplantation, however, this brittle diabetes
can be ameliorated.19 As a result, reoperative surgery with exten-
sive resection is a viable option for select patients and may be
preferable to anastomotic revision.
Conclusions
Stricture of the pancreaticojejunostomy anastomosis after pan-
creatic head resection for benign disease can present with recur-
rent pancreatitis and pancreatic pain, and is probably not a
rare event, particularly in patients with chronic pancreatitis.
Secretin-stimulated MRCP has good specificity in the diagnosis
of anastomotic obstruction, but lacks sensitivity. Operative pan-
creaticojejunal revision is safe, but rarely effective as a means of
pain relief in patients with the pain syndrome associated with
chronic pancreatitis.
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